Ifsofamide and Le cells present - a phase IV clinical study of FDA data
Summary:
We study 40 people who take Ifsofamide (ifosfamide) or have Le cells present. No report of Le cells present is found in people who take Ifsofamide.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Ifsofamide?
Ifsofamide has active ingredients of ifosfamide. eHealthMe is studying from 5 Ifsofamide users. Check the latest studies of Ifsofamide.
What is Le Cells Present?
Le cells present is found to be associated with 8 drugs and 33 conditions by eHealthMe. Check the latest studies of Le cells present.
No report is found.
Do you take Ifsofamide and have Le cells present?
- Check whether Le cells present is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ifsofamide:
- Ifsofamide (5 reports)
Le cells present treatments and more:
- Le cells present (35 reports)
How severe was Le cells present and when was it recovered:
Expand to all the drugs that have ingredients of ifosfamide:
Browse all side effects of Ifsofamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Le cells present:
Browse all the conditions that are associated with Le cells present:
How the study uses the data?
The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifsofamide) and Ifsofamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Muscle Spasms and drugs of ingredients of sumatriptan succinate - 4 seconds ago
- Could Augmentin '125' cause Coronary Artery Disease Aggravated? - 12 seconds ago
- Back Pain in Pantoprazole Sodium, how severe and when it was recovered? - 18 seconds ago
- Could Glipizide cause Sneezing? - 18 seconds ago
- Post Inflammatory Pigmentation Change and drugs of ingredients of gadodiamide - 21 seconds ago
- Drug interactions of Briviact and Onfi - 23 seconds ago
- Drug interactions of Actrapid and Nimbex - 25 seconds ago
- Celebrex and Cough for Men aged 30-39 - 26 seconds ago
- Celebrex and Coughing for Men aged 30-39 - 27 seconds ago
- Could Paroxetine cause Micturition Disorder? - 27 seconds ago